Population balance model development, validation, and prediction of CQAs of a high-shear wet granulation process: Towards QbD in drug product pharmaceutical manufacturing

Anwesha Chaudhury, Dana Barrasso, Preetanshu Pandey, Huiquan Wu, Rohit Ramachandran

Research output: Contribution to journalArticlepeer-review

32 Scopus citations

Abstract

This paper focuses on the predictive model development for a pharmaceutically relevant model granulation process. A population balance modeling (PBM) framework has been employed for modeling purposes which is then utilized to obtain accurate predictions of the process. The model is aligned to adequately describe the high-shear mode of granulation operation in a batch process. The model is calibrated using the particle swarm algorithm (PSA) in the form of a multiobjective optimization problem. The multiobjective optimization problem was implemented based on the ε-constraint method which involves the handling of multiple cost functions in the form of constraints with the minimization of one primary objective function from the entire set of cost functions. The resultant solutions obtained from the model are Pareto optimal. The effects of the impeller speed, liquid-to-solid ratio, and wet massing time on the particle size distributions were characterized, and predicted size distributions were in agreement with experimental results. The predictive model framework lends itself to the quality by design (QbD) initiative undertaken by the US Food and Drug Administration (US FDA).

Original languageEnglish (US)
Pages (from-to)53-64
Number of pages12
JournalJournal of Pharmaceutical Innovation
Volume9
Issue number1
DOIs
StatePublished - Mar 2014

All Science Journal Classification (ASJC) codes

  • Pharmaceutical Science
  • Drug Discovery

Keywords

  • Granulation
  • Multidimensional population balance model
  • Multiobjective optimization
  • Particle size distribution
  • Predictive modeling
  • QbD

Fingerprint

Dive into the research topics of 'Population balance model development, validation, and prediction of CQAs of a high-shear wet granulation process: Towards QbD in drug product pharmaceutical manufacturing'. Together they form a unique fingerprint.

Cite this